Literature DB >> 15158152

Green tea catechins inhibit neointimal hyperplasia in a rat carotid arterial injury model by TIMP-2 overexpression.

Xian Wu Cheng1, Masafumi Kuzuya, Takeshi Sasaki, Shigeru Kanda, Norika Tamaya-Mori, Teruhiko Koike, Keiko Maeda, Eisei Nishitani, Akihisa Iguchi.   

Abstract

OBJECTIVE: Although it has been demonstrated that the antioxidant properties of tea catechins reduce atherosclerotic lesions in various animal models of hyperlipidemia, it is not yet clear whether these catechins prevent hyperlipidemia-independent arterial remodeling induced by balloon angioplasty. We evaluated the influence of the administration of the tea extract on vascular remodeling in a rat carotid artery balloon-injury model. METHODS AND
RESULTS: Male Wistar rats were supplied drinking water with or without green tea extract (1 mg/ml) supplement. Administration of the tea extract reduced the area of the intima (30%) and the ratio of the intimal area to the medial area (36.2%) in injured arteries compared with those of control rats at 14 days after the injury. Real-time RT-PCR, Western blot, and gelatin zymography revealed a significant increase in tissue inhibitor of matrix metalloproteinase (MMP)-2 (TIMP-2) expression as well as a significant reduction of gelatinolytic net activity and activated MMP-2 levels in the injured arteries as a result of the administration of the tea extract compared with those of control group. Similarly, epigallocatechin-3-gallate, a major constituent of green tea catechins, significantly upregulated TIMP-2 expression in cultured smooth muscle cells. Immunohistochemical analysis showed that the increase of TIMP-2 protein occurred preferentially in the developing neointima.
CONCLUSION: These results indicate that catechins inhibit intimal hyperplasia in a rat balloon-injury model through the upregulation of TIMP-2 expression to modulate MMP activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15158152     DOI: 10.1016/j.cardiores.2004.01.023

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  7 in total

1.  Localization of cysteine protease, cathepsin S, to the surface of vascular smooth muscle cells by association with integrin alphanubeta3.

Authors:  Xian Wu Cheng; Masafumi Kuzuya; Kae Nakamura; Qun Di; Zexuan Liu; Takeshi Sasaki; Shigeru Kanda; Hai Jin; Guo-Ping Shi; Toyoaki Murohara; Mitsuhiro Yokota; Akihisa Iguchi
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

2.  Epigallocatechin-3-gallate is a potent phytochemical inhibitor of intimal hyperplasia in the wire-injured carotid artery.

Authors:  Vicente Orozco-Sevilla; Rotem Naftalovich; Thomas Hoffmann; Dennis London; Eric Czernizer; Chenzi Yang; Alan Dardik; Herbert Dardik
Journal:  J Vasc Surg       Date:  2013-03-26       Impact factor: 4.268

3.  Superoxide-dependent cathepsin activation is associated with hypertensive myocardial remodeling and represents a target for angiotensin II type 1 receptor blocker treatment.

Authors:  Xian Wu Cheng; Toyoaki Murohara; Masafumi Kuzuya; Hideo Izawa; Takeshi Sasaki; Koji Obata; Kohzo Nagata; Takao Nishizawa; Masakazu Kobayashi; Takashi Yamada; Weon Kim; Kohji Sato; Guo-Ping Shi; Kenji Okumura; Mitsuhiro Yokota
Journal:  Am J Pathol       Date:  2008-06-26       Impact factor: 4.307

4.  Rosuvastatin reduces neointima formation in a rat model of balloon injury.

Authors:  M R Preusch; A Vanakaris; F Bea; N Ieronimakis; T Shimizu; M Konstandin; S Morris-Rosenfeld; C Albrecht; A Kranzhöfer; H A Katus; E Blessing; R Kranzhöfer
Journal:  Eur J Med Res       Date:  2010-11-25       Impact factor: 2.175

Review 5.  Role of Polyphenols and Other Phytochemicals on Molecular Signaling.

Authors:  Swapna Upadhyay; Madhulika Dixit
Journal:  Oxid Med Cell Longev       Date:  2015-06-09       Impact factor: 6.543

6.  Association of SNPs in the TIMP-2 gene and large artery atherosclerotic stroke in southern Chinese Han population.

Authors:  Tie Guo; Haizhen Hao; Lv Zhou; Feng Zhou; Dan Yu
Journal:  Oncotarget       Date:  2017-12-18

Review 7.  Plant-Derived Products for Treatment of Vascular Intima Hyperplasia Selectively Inhibit Vascular Smooth Muscle Cell Functions.

Authors:  Kang Xu; Mohanad Kh Al-Ani; Xin Pan; Qingjia Chi; Nianguo Dong; Xuefeng Qiu
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-11       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.